Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Radius Health, Inc.
With
PRA Health Sciences
This is a retrospective observational cohort study using healthcare administrative claims data from the USA.
This study will use anonymized patient claims data from PRA's Symphony Health Patient Source Integrated Dataverse (IDV) database including the enhanced hospital data. Data are routinely collected in healthcare encounters from all available healthcare sites (inpatient hospital, outpatient hospital, physician office, pharmacy, etc.) for all types of provided services including specialty, preventive care, and office-based treatments.
The patients for inclusion in the study analyses will be identified based on the prescribed anabolic therapy filled (ABL or TPTD). The identification period (May 1, 2017 to June 30, 2019) was chosen to coincide with the date of the FDA approval of ABL in the USA.
Age
50–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who are 50 years or older
≥1 prescription fill for ABL or TPTD during the identification period
≥ 1 claim for medical or hospital visit and a pharmacy claim in the 12 months before the index date
You may not be if
Paget's disease
Malignancy, except for nonmelanoma skin cancers, carcinoma in-situ of the cervix, ductal carcinoma in-situ of breast
Indicators of high disease burden and high risk of death
With prior index anabolic treatment
Switch to a different anabolic treatment after index date